Kidney transplant medication: promising monthly infusion trial in 2026

A new UCSF phase 2 trial offers early hope that kidney transplant medication could one day shift from a daily cocktail of tablets to a monthly infusion, with the potential to reduce side effects and protect the donor kidney for longer. We explain what the researchers found and what it could mean for kidney transplant patients in the UK.
APOL1 kidney disease: 2026 research deepens understanding for African heritage families

New research from the University of Ghana sheds light on how the APOL1 gene shapes kidney disease risk in people of West African heritage. We explain what this means for UK patients, why it matters for Greater Manchester communities, and how it points the way to fairer screening and more personal care.
Gout and CKD: New Research on Why Nephrology Care Makes a Difference in 2026

Three new studies presented at NKF 2026 highlight why nephrology care matters for people managing gout and CKD together. Here is what we learned.
New high potassium treatment recommended for more kidney patients in 2026

NICE has issued new draft guidance that could more than double the number of kidney patients eligible for high potassium treatment with sodium zirconium cyclosilicate.
CKD symptom burden: new study reveals important gender differences in advanced kidney disease

A European study of over 1,100 older adults shows women with advanced CKD report more symptoms, while men see faster symptom progression. We explore what CKD symptom burden research means for patient care.
CMV vaccine research: new hope for kidney transplant patients in 2026

New UK research, funded by Kidney Research UK and led by UCL, reveals how a promising CMV vaccine produces antibodies that could better protect kidney transplant patients from this common virus.
Art on Dialysis: how creativity is supporting wellbeing during treatment

A new NHS Highland initiative called Art on Dialysis brings an artist in residence to a renal unit, offering kidney patients creative activity during their long treatment sessions and addressing the emotional challenges of dialysis.
Kidney peer educators: Peterborough pilot to reach at-risk communities

Kidney Research UK is recruiting kidney peer educators in Peterborough to help Eastern European and South Asian communities spot the signs of kidney disease early, in a pilot that could expand UK-wide.
New kidney treatments: promising advances for CKD patients in 2026

A March 2026 Scientific American report highlights new kidney treatments emerging from research into diabetes, autoimmune conditions, and smarter diagnostics. We look at what these advances could mean for CKD patients.
Could a small skin patch from a donor help detect transplant rejection earlier?

For anyone who has received a transplant, or who is waiting for one, the fear of rejection is something that stays with you. After the initial relief of receiving a new organ, the reality of long-term monitoring begins: regular blood tests, clinic visits, and sometimes invasive biopsies to check whether the body is accepting or […]